Related Experiment Video
Updated: Mar 14, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
ECCMID 2016: addressing the burden of recurrent Clostridium difficile infections
1Department of General, Visceral & Thoracic Surgery, Academic Hospital of Medical University Hannover, Peine, Germany.
The 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) highlighted Clostridium difficile infections. This meeting focused on the diagnosis, prevention, and treatment of healthcare-associated infections, particularly recurrent C. difficile.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Healthcare-Associated Infections
Background:
- The European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) is a key annual event for professionals in the field.
- ECCMID 2016 convened in Amsterdam, attracting over 11,600 experts from 120+ countries.
- Healthcare-associated infections, particularly those caused by Clostridium difficile, remain a significant global health concern.
Purpose of the Study:
- To provide a platform for discussing advancements in the diagnosis, prevention, and treatment of healthcare-associated infections.
- To address the specific challenges posed by Clostridium difficile infections, including recurrent cases.
- To foster collaboration and knowledge sharing among clinical microbiologists and infectious disease physicians worldwide.
Main Methods:
- The abstract does not detail specific methods used in presented studies.
- Information was disseminated through congress presentations and discussions.
- Focus was on clinical case studies and research findings related to infectious diseases.
Main Results:
- ECCMID 2016 served as a crucial forum for learning about the latest developments in managing healthcare-associated infections.
- Recurrent Clostridium difficile infections were identified as a major concern due to their severe impact.
- The congress facilitated discussions on strategies for managing vulnerable patients in healthcare settings.
Conclusions:
- ECCMID 2016 underscored the ongoing importance of addressing Clostridium difficile infections.
- Effective diagnosis, prevention, and treatment strategies are vital for mitigating the impact of these infections.
- Continued vigilance and collaboration are necessary among healthcare professionals to combat healthcare-associated infections.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

